Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The AAA+ ATPase subunits of the 19S regulatory proteasome particle, comprising PSMC1 through PSMC6, form a hexameric ring that serves as the mechanical engine of the 26S proteasome (Source: UniProt). These subunits utilize ATP hydrolysis to recognize, unfold, and translocate polyubiquitinated protein substrates into the 20S core for degradation (Source: Annual Review of Biochemistry, PMID: 30089918). This process is essential for maintaining cellular proteostasis and regulating key processes such as the cell cycle and DNA repair (Source: PNAS, PMID: 27851968). In cancers like multiple myeloma, the proteasome is often upregulated, making these subunits attractive therapeutic targets (Source: Frontiers in Oncology, PMID: 32983998). While current clinical inhibitors like bortezomib target the 20S core, the 19S ATPases are emerging as targets for novel small molecules designed to overcome drug resistance (Source: Journal of Medicinal Chemistry, PMID: 29161035). Inhibition of these ATPases leads to the accumulation of misfolded proteins and triggers apoptosis via the unfolded protein response (Source: Cell Death & Disease, PMID: 23154387).
Inhibition of ATP-dependent protein unfolding and translocation into the 20S proteasome core, leading to proteotoxic stress and apoptosis.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 19S proteasome AAA-ATPase subunits (PSMC1-PSMC6) (PSMC).